Minerva Neurosciences Continues To Rally, Up 300% In A Week

Minerva Neurosciences Inc NERV shares are trading higher by $1.60 (15 percent) at $13.90 in Wednesday's session. It has backed off its intra-day and all-time high made earlier in the session at $14.54.

The issue continues to benefit from meeting primary and secondary endpoints for MIN-101 Monotherapy. Since making the announcement on May 25, the issue has added over $10, or over 300 percent, since its May 25 close of $3.54.